| Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis DJ Hicklin, LM Ellis Journal of clinical oncology 23 (5), 1011-1027, 2005 | 3667 | 2005 |
| Raise standards for preclinical cancer research CG Begley, LM Ellis Nature 483 (7391), 531-533, 2012 | 3215 | 2012 |
| Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases EK Abdalla, JN Vauthey, LM Ellis, V Ellis, R Pollock, KR Broglio, K Hess, ... Annals of surgery 239 (6), 818, 2004 | 2110 | 2004 |
| VEGF-targeted therapy: mechanisms of anti-tumour activity LM Ellis, DJ Hicklin Nature reviews cancer 8 (8), 579-591, 2008 | 1990 | 2008 |
| Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Y Takahashi, Y Kitadai, CD Bucana, KR Cleary, LM Ellis Cancer research 55 (18), 3964-3968, 1995 | 1841 | 1995 |
| Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients SA Curley, F Izzo, P Delrio, LM Ellis, J Granchi, P Vallone, F Fiore, ... Annals of surgery 230 (1), 1, 1999 | 1574 | 1999 |
| Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis G Niu, KL Wright, M Huang, L Song, E Haura, J Turkson, S Zhang, ... Oncogene 21 (13), 2000-2008, 2002 | 1558 | 2002 |
| The implications of angiogenesis for the biology and therapy of cancer metastasis IJ Fidler, LM Ellis Cell 79 (2), 185-188, 1994 | 1471 | 1994 |
| Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and … R Fukuda, K Hirota, F Fan, Y Do Jung, LM Ellis, GL Semenza Journal of Biological Chemistry 277 (41), 38205-38211, 2002 | 1016 | 2002 |
| Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis SA Curley, F Izzo, LM Ellis, JN Vauthey, P Vallone Annals of surgery 232 (3), 381, 2000 | 969 | 2000 |
| Simplified staging for hepatocellular carcinoma JN Vauthey, GY Lauwers, NF Esnaola, KA Do, J Belghiti, N Mirza, ... Journal of clinical oncology 20 (6), 1527-1536, 2002 | 852 | 2002 |
| Antiangiogenic therapy in oncology: current status and future directions GC Jayson, R Kerbel, LM Ellis, AL Harris The Lancet 388 (10043), 518-529, 2016 | 746 | 2016 |
| MMAC1/PTEN Mutations in Primary Tumor Specimens and Tumor Cell Lines DHF Teng, R Hu, H Lin, T Davis, D Iliev, C Frye, B Swedlund, KL Hansen, ... Cancer research 57 (23), 5221-5225, 1997 | 665 | 1997 |
| Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases DG Blazer 3rd, Y Kishi, DM Maru, S Kopetz, YS Chun, MJ Overman, ... J Clin Oncol 26 (33), 5344-5351, 2008 | 661 | 2008 |
| Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition NA Dallas, L Xia, F Fan, MJ Gray, P Gaur, G Van Buren, S Samuel, ... Cancer research 69 (5), 1951-1957, 2009 | 613 | 2009 |
| Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines AD Yang, F Fan, ER Camp, G van Buren, W Liu, R Somcio, MJ Gray, ... Clinical cancer research 12 (14), 4147-4153, 2006 | 578 | 2006 |
| Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with … S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ... Journal of clinical oncology 28 (3), 453, 2010 | 525 | 2010 |
| Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies AS Pearson, F Izzo, RYD Fleming, LM Ellis, P Delrio, MS Roh, J Granchi, ... The American journal of surgery 178 (6), 592-598, 1999 | 494 | 1999 |
| HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate … MJ Gray, J Zhang, LM Ellis, GL Semenza, DB Evans, SS Watowich, ... Oncogene 24 (19), 3110-3120, 2005 | 487 | 2005 |
| Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases D Ribero, H Wang, M Donadon, D Zorzi, MB Thomas, C Eng, DZ Chang, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 471 | 2007 |
Timothy M. PawlikChair, Department of Surgery, The Ohio State University在 osumc.edu 的电子邮件经过验证
Timothy M. PawlikChair, Department of Surgery, The Ohio State University在 osumc.edu 的电子邮件经过验证